Michael Terrence Gibbs - Mar 24, 2023 Form 4/A - Amendment Insider Report for T2 Biosystems, Inc. (TTOO)

Role
General Counsel
Signature
/s/ John Sprague, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Mar 24, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/5/2023, 02:30 PM
Date Of Original Report
Mar 28, 2023
Previous filing
Mar 9, 2023
Next filing
Apr 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +334 +5.13% 6.85K Mar 24, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -334 -100% $0.00* 0 Mar 24, 2023 Common Stock 334 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Form 4, as originally filed, incorrectly reported the amount of shares acquired as a result of the vesting of the Restricted Stock Units as 333.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3 On March 24, 2020 the reporting person was granted 1,000 RSU's that vest in three equal annual installments commencing on March 24, 2021